Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0001-9225-3010Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Ismail Mustafa Meraz, Shuhong Wu, Yi Xu…·Jack A. Roth
This study identifies PI3K-mTOR pathway inhibition as a strategy to overcome acquired resistance to KRASG12C inhibitors in NSCLC by targeting 4E-BP1.
Brian S. White, X. Woo, Soner Koc…·Jeffrey H. Chuang
The paper presents a pan-cancer PDX histology image repository with genomic and pathological annotations for deep learning analysis of tumor regions and xenograft-transplant lymphoproliferative disorder prediction.
Licai Huang, Jing Wang, Bingliang Fang…·Min Jin Ha
CombPDX evaluates drug synergism in PDX models using tumor growth curves and provides statistical metrics and inference procedures for combination effects.